Ann Watkins
Associate Director, Medical Affairs, EUR/International Jazz Pharmaceuticals plc
Seminars
This fast-paced session delivers practical, on-the-ground solutions to common EAP challenges. Featuring a series of concise, ten-minute spotlights from leading biopharma, each presentation highlights a single innovation or tactic that helped unlock access, streamline processes, or support patient continuity. Designed to fuel actionable discussion, this session goes beyond the theory – focusing on what’s actually working, and where we go next.
This session brings together two real-world case studies to explore how organisations have managed the transition from clinical trial systems into post-trial access.
- Managing the transition from trial supply to post trial access without disrupting patient treatment
- Resetting site expectations around ordering, reporting, and documentation outside trial frameworks
- Addressing practical blockers in complex regions where PTA setup is slower, less defined, or inconsistently interpreted
- Deciding when post trial access can accommodate limited data collection and when patients must remain in extension studies instead